Concepedia

Swaroopkumar Vakkalanka

SV

Statistics

Publications

4

Citations

125

H-Index

4

Active since

2012

Affiliations

PRIST University(Current)

Horizon Therapeutics (United Kingdom)

Swaroopkumar Vakkalanka is an author at PRIST University specializing in pharmacokinetics, pharmacotherapy, and drug analysis.

Top concepts

Publications per year

2012–2014

4

Publications

4

Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC–MS/MS: Application to a pharmacokinetic study

Sridhar Veeraraghavan, Srikant Viswanadha, Satheeshmanikandan Thappali et al. · Journal of Pharmaceutical and Biomedical Analysis · 2014 · 59 citations

, , +8

Simultaneous quantification of ruxolitinib and nilotinib in rat plasma by LC–MS/MS: Application to a pharmacokinetic study

Sridhar Veeraraghavan, Satheeshmanikandan Thappali, Srikant Viswanadha et al. · Journal of Pharmaceutical and Biomedical Analysis · 2014 · 28 citations

, , +9

Simultaneous quantification of idelalisib, fludarabine and lenalidomide in rat plasma by using high-performance liquid chromatography coupled with heated electrospray ionization tandem mass spectrometry

Sridhar Veeraraghavan, Satheeshmanikandan Thappali, Srikant Viswanadha et al. · Journal of Chromatography B · 2014 · 21 citations

, , +11

Simultaneous Determination of Methotrexate, Dasatinib and its Active Metabolite N- Deshydroxyethyl Dasatinib in Rat Plasma by LC-MS/MS: Method Validation and Application to Pharmacokinetic Study

Satheeshmanikandan Thappali, Kanthikiran V. S. Varanasi, Sridhar Veeraraghavan et al. · Arzneimittelforschung · 2012 · 17 citations

, , +18

Rows per page

1–4 of 4